BioSpace News Archive

Genetown

US Rep Jake Auchincloss to Visit Mansfield Bio-Incubator

On February 23, 2022 U.S. Rep. Jake Auchincloss, D-Newton will be touring the Mansfield Bio-Incubator located at 241 Francis Ave. in Mansfield, MA

February 18, 2022

·

1 min read

Biotech Bay

Innovaccer Recognized by Gartner in Report Encouraging Adoption of FHIR to Jump-Start Clinical Data IntegrationGartner recognizes Innovaccer as a Representative Vendor for clinical data integration (CDI)

Innovaccer Inc., the Health Cloud company, today announced it has been listed as a partner vendor of choice in the January 2022 Gartner® report, “Quick Answer: Use FHIR to Jump-Start Clinical Data Integration for U.S. Healthcare Payers.”

February 18, 2022

·

5 min read

Pharm Country

Cigna Corporation Announces Cynthia Ryan as Chief Human Resources Officer as Longtime CHRO John Murabito Retires

Cigna Corporation, a global health service company, announced that John Murabito, longtime Chief Human Resources Officer and current Chief Administrative Officer, will retire on April 1.

February 18, 2022

·

4 min read

Pharm Country

Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing single molecule protein sequencing, today announced that it will be participating virtually in the 42nd Annual Cowen Health Care Conference.

February 18, 2022

·

1 min read

FDA

Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the Freezor™ and Freezor™ Xtra Cardiac Cryoablation Catheters are approved by the U.S. Food and Drug Administration (FDA) and are the only ablation catheters approved to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

February 18, 2022

·

7 min read

Business

OSE Immunotherapeutics Announces Appointment of Alexandre Lebeaut as an Independent Member of the Board of Directors

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the appointment by cooptation of Alexandre Lebeaut as an independent Director of the Company*.

February 18, 2022

·

6 min read

Drug Development

Second Genome Presents New Preclinical Data for SG-5-00455, Potential First-in-Class Development Candidate Targeting PAI-1/2 for the Treatment of Inflammatory Bowel Disease (IBD), at the 17th Congress of ECCO

Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers, announced preclinical data for SG-5-00455, the Company’s development candidate.

February 18, 2022

·

4 min read

Angle PLC Announces Issue of Equity - Feb 18, 2022

ANGLE plc, a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 6,667 new ordinary shares of £0.10 each in the Company.

February 18, 2022

·

5 min read

Drug Development

Data from Codiak’s exoASO™-STAT6 Preclinical Development Program for the Treatment of Primary and Metastatic Hepatic Cancers Published in Science Advances

Codiak BioSciences, Inc. (NASDAQ: CDAK), today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science’s journal, Science Advances.

February 18, 2022

·

5 min read

Biotech Beach

Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Feb 18, 2022

Organovo Holdings, Inc., announced that it has granted a stock option to purchase 50,000 shares of common stock to one new employee.

February 18, 2022

·

2 min read